Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Freethiadine in Healthy Volunteers and Chronic Hepatitis B
NCT05391360Phase 1Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Oct 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of freethiadine in Chronic Hepatitis B (CHB) (4 arms), sponsored by Sunshine Lake Pharma. Primary endpoints: Adverse Events, Area Under the Curve and 1 more. Started Oct 2021; status: completed.
02
Drugs
freethiadine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05391360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05391360.